Marker Therapeutics (MRKR) Live Share Price, Invest From India

Marker Therapeutics Stock Performance

as on October 5, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.02
Day's Price Range
$1.08
$1.05
2.86%
Downside
2.86%
Upside
52 Week's Low
52 Week's High
$0.84
52-Week Price Range
$2.46
$1.05
20.00%
Downside
134.29%
Upside

Marker Therapeutics share price movements today

Previous Close: $1.05
Open: $1.08
Volume: 255.8K
Market Cap: $17.5M
Day's Low - High: $1.02 - $1.08
52 Week Low - High: $0.84 - $2.46

Marker Therapeutics Historical Returns

1 Month Return: -15.32 %
3 Month Return: -28.57 %
1 Year Return: + 9.96 %
3 Year Return: -76.08 %
5 Year Return: -93.71 %

Marker Therapeutics Stock Fundamentals & Key Indicators

Check Marker Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.5M

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.18

Industry PE ratio

-3.02

PEG Ratio

-0.02

EBITDA

-8.7M

Revenue (TTM)

1.2M

Profit Margin

-320.83%

Return On Equity TTM

-56.96%

Marker Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Marker Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Marker Therapeutics	Buy	$17.5M	-93.71%	-2.18	-320.83%	0.00%
Revolution Medicines	StrongBuy	$44.3B	637.21%	-23.32	0.00%	0.00%
Moderna	Neutral	$75.9B	-42.79%	-23.81	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$127.9B	185.14%	29.14	86.04%	0.00%
Regeneron	Buy	$75.7B	33.45%	17.55	84.86%	0.50%

Stock Returns calculator for Marker Therapeutics Stock including INR - Dollar returns

The Marker Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Marker Therapeutics investment value today

Current value as on today

₹1,19,352

Returns

₹19,352

(+19.35%)

Returns from Marker Therapeutics Stock

₹9,959 (+9.96%)

Dollar Impact

₹9,393 (+9.39%)

Analyst Recommendation on Marker Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Marker Therapeutics. Average target price of $7.87

Marker Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Marker Therapeutics.

What analysts predicted

86.66%UPSIDE

Target Price

$7.87

Current Price

$1.05

Analyzed by

1 Analysts

High

$10

Target

$7.87

Low

$10

Marker Therapeutics target price $7.87, a slight upside of 86.66% compared to current price of $1.05. According to 1 analysts rating.

Indian Investors' Interest in Marker Therapeutics Stock

Search interest for Marker Therapeutics Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 5, 2026 to October 5, 2026

Change:-33% versus previous 30 day period

Marker Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	1	1	1	1	0	0	1	-	-	-
Gross Profit	-1	-1	-1	-1	-2	-3	-1	-	-2	-
Operating Income	-2	-2	-2	-2	-4	-4	-2	-1	-4	-2
EBITDA	-2	0	0	-2	-	-4	-1	-1	-3	-1
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	2	2	-	4	0	-	-	-	-
Income Before Tax	-2	-2	-2	-2	-4	-4	-1	-1	-3	-1
Income Tax Expense	0	-	-	-	-	-	-	0	-	-
Net Income	-2	-2	-2	-2	-4	-4	-1	-1	-3	-1
Net Profit Margin	-147.73%	-106.98%	-99.74%	-80.22%	-798.14%	-385.04%	-90.26%	0.00%	0.00%	0.00%

Marker Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	0	0	0	0	1	3	3	6	-
Gross Profit	-5	-123	-12	-18	-1	-8	-7	-6	-
Operating Income	-11	-148	-22	-28	-39	-19	-14	-11	-12
EBITDA	-11	-147	-22	-27	-38	-16	-11	-10	-12
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	11	148	0	1	3	2	2	0	-
Income Before Tax	-10	-147	-21	-28	-41	-19	-14	-10	-12
Income Tax Expense	-	0	-	-	-	-	0	0	0
Net Income	-10	-147	-21	-28	-41	-29	-8	-10	-12
Net Profit Margin	-2768.43%	-60094.95%	-5887.41%	-3944.86%	-154.70%	-240.64%	-214.60%	-104.33%	0.00%

Marker Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	-2	-2	-2	-4	-4	-1	-1	-3	-1
Operating Cash Flow	-2	-3	-3	1	-5	-1	-2	-1	-1	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	0	9	-	-	-
Change in Cash	-2	-3	-3	1	-5	-1	7	-1	-1	-3

Marker Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	-10	-147	-21	-28	-41	-19	-14	-10	-12
Operating Cash Flow	-8	-14	-18	-20	-27	-26	-16	-10	-12
Investing Cash Flow	-	0	0	-9	-3	-4	18	-	-
Financing Cash Flow	5	71	0	6	52	0	1	14	9
Change in Cash	-2	56	-17	-22	22	-31	3	4	-2

Global Institutional Holdings in Marker Therapeutics

Check out the Institutions with significant holdings in Marker Therapeutics.

Funds	Holdings
Vanguard	2.56%
VANGUARD INDEX FUNDS	2.34%
Dennis J Purcell	1.95%
Fidelity Concord Street Trust	0.66%
Scott Jarred	0.11%

Marker Therapeutics News & Key Events

Insights on Marker Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.17M → -1.82M (in $), with an average increase of 74.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 556.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.5% return, outperforming this stock by 156.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.23M → 1.10M (in $), with an average decrease of 10.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, MRKR stock has moved down by -6.7%

About Marker Therapeutics

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary MultiTAA-specific T cell technology. This method involves producing T cells that are not genetically modified but are specifically designed to target tumors. These specialized T cells can identify multiple antigens associated with tumors, allowing them to effectively eliminate cancer cells that express these markers. Marker Therapeutics' MultiTAA-specific T cell therapies encompass patient-derived (autologous) T cells for treating lymphoma and various solid tumors, as well as donor-derived (allogeneic) T cells for acute myeloid leukemia and acute lymphoblastic leukemia. They also provide "off-the-shelf" solutions applicable to a range of diseases. In addition to T cell therapies, the company is advancing peptide-based immunotherapeutic vaccines. This pipeline includes TPIV100/110, developed to combat breast and ovarian cancer cells, and TPIV200, which is currently undergoing Phase 2 clinical trials for the treatment of breast and ovarian cancers. Founded in 1999, Marker Therapeutics maintains its headquarters in Houston, Texas.

Organisation	Marker Therapeutics
Headquarters	2450 Holcombe Blvd, Houston, TX, 77021, US
Industry	Biotechnology
CEO	Juan F. Vera

Key Management of Marker Therapeutics

Name	Title
Dr. Juan F. Vera M.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly	Director of Administration
Dr. Maria-Bernadette Madel Ph.D.	Director of Corporate Operations & External Communications
Mr. Edmund Cheung	Vice President of Human Resources
Patricia Allison	Head of Clinical Operations
Ms. Mary Newman Ph.D.	Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr., Ph.D.	Senior Director of Molecular Biology & Virology

FAQs

What is Marker Therapeutics share price today?

Marker Therapeutics share price today is $1.05 as on October 5, 2026 at 8:45 am IST at the close of the market. Marker Therapeutics share today touched a day high of $1.08 and a low of $1.02.

What is the 52 week high and 52 week low for Marker Therapeutics share?

Marker Therapeutics share touched a 52 week high of $2.46 on January 8, 2026 and a 52 week low of $0.84 on November 10, 2025. Marker Therapeutics stock price today i.e. October 5, 2026 at 8:45 am IST is closed at $1.05,which is 57.32% down from its 52 week high and 25.00% up from its 52 week low.

What is Marker Therapeutics's market capitalisation today?

Marker Therapeutics market capitalisation is $0.00T as on October 5, 2026 at 8:45 am IST.

How to invest in Marker Therapeutics Stock (MRKR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Marker Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Marker Therapeutics Stock (MRKR) from India?

Indian investors can start investing in Marker Therapeutics (MRKR) shares with as little as ₹96.300003051758 or $1 (as of October 5, 2026 at 11:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Marker Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 5, 2026 at 11:37 am IST). Based on Marker Therapeutics share’s latest price of $1.05 as on October 5, 2026 at 8:45 am IST, you will get 9.5238 shares of Marker Therapeutics. Learn more about fractional shares .

What are the returns that Marker Therapeutics has given to Indian investors in the last 5 years?

Marker Therapeutics stock has given -93.71% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?